Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

George J, Patel T.

Semin Liver Dis. 2015 Feb;35(1):63-74. doi: 10.1055/s-0034-1397350. Epub 2015 Jan 29. Review.

2.

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv XW, Li J.

Cancer Lett. 2014 Mar 1;344(1):20-27. doi: 10.1016/j.canlet.2013.10.021. Epub 2013 Oct 30. Review.

PMID:
24183851
3.

Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.

Hou W, Bonkovsky HL.

World J Gastroenterol. 2013 Nov 28;19(44):7836-45. doi: 10.3748/wjg.v19.i44.7836. Review.

4.

[CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].

Eguchi H, Doki Y, Mori M.

Nihon Geka Gakkai Zasshi. 2015 Nov;116(6):366-9. Japanese.

PMID:
26845888
5.

Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma.

Huang JL, Zheng L, Hu YW, Wang Q.

Carcinogenesis. 2014 Mar;35(3):507-14. doi: 10.1093/carcin/bgt405. Epub 2013 Dec 2. Review.

PMID:
24296588
6.

Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.

Deng L, Yang SB, Xu FF, Zhang JH.

J Exp Clin Cancer Res. 2015 Feb 19;34:18. doi: 10.1186/s13046-015-0136-7.

7.

Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.

Niu ZS, Niu XJ, Wang WH.

World J Gastroenterol. 2017 Aug 28;23(32):5860-5874. doi: 10.3748/wjg.v23.i32.5860. Review.

8.

Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.

Li C, Chen J, Zhang K, Feng B, Wang R, Chen L.

Cell Physiol Biochem. 2015;36(2):423-34. doi: 10.1159/000430109. Epub 2015 May 11. Review.

9.

Long noncoding RNAs in liver cancer: what we know in 2014.

Zhao J, Greene CM, Gray SG, Lawless MW.

Expert Opin Ther Targets. 2014 Oct;18(10):1207-18. doi: 10.1517/14728222.2014.941285. Epub 2014 Aug 22. Review.

PMID:
25145388
10.

MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.

Ge Y, Yan X, Jin Y, Yang X, Yu X, Zhou L, Han S, Yuan Q, Yang M.

PLoS Genet. 2015 Dec 28;11(12):e1005726. doi: 10.1371/journal.pgen.1005726. eCollection 2015 Dec. Erratum in: PLoS Genet. 2016 Jan;12(1):e1005825.

11.

Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.

Qiu L, Tang Q, Li G, Chen K.

Life Sci. 2017 Dec 15;191:273-282. doi: 10.1016/j.lfs.2017.10.007. Epub 2017 Oct 4. Review.

PMID:
28987633
12.

Role of microRNAs in hepatocellular carcinoma.

Liu LN, Li DD, Xu HX, Zheng SG, Zhang XP.

Front Biosci (Landmark Ed). 2015 Jun 1;20:1056-67. Review.

PMID:
25961544
13.

Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.

Chen CL, Tseng YW, Wu JC, Chen GY, Lin KC, Hwang SM, Hu YC.

Biomaterials. 2015 Mar;44:71-81. doi: 10.1016/j.biomaterials.2014.12.023. Epub 2015 Jan 12.

PMID:
25617127
14.

The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention.

Zou H, Shao CX, Zhou QY, Zhu GQ, Shi KQ, Braddock M, Huang DS, Zheng MH.

Expert Rev Gastroenterol Hepatol. 2016;10(3):331-40. doi: 10.1586/17474124.2016.1116382. Epub 2015 Nov 23. Review.

PMID:
26558504
15.

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Giordano S, Columbano A.

Hepatology. 2013 Feb;57(2):840-7. doi: 10.1002/hep.26095. Epub 2012 Dec 26. Review.

16.

Noncoding RNAs in cancer and cancer stem cells.

Huang T, Alvarez A, Hu B, Cheng SY.

Chin J Cancer. 2013 Nov;32(11):582-93. doi: 10.5732/cjc.013.10170. Review.

17.

The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.

D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N, Cascinu S.

Molecules. 2014 May 19;19(5):6393-406. doi: 10.3390/molecules19056393. Review.

18.

Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.

Zhang Q, Pu R, Du Y, Han Y, Su T, Wang H, Cao G.

Cancer Lett. 2012 Aug 1;321(1):1-12. doi: 10.1016/j.canlet.2012.03.011. Epub 2012 Mar 15. Review.

PMID:
22425745
19.

MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications.

Sun J, Lu H, Wang X, Jin H.

ScientificWorldJournal. 2013;2013:924206. doi: 10.1155/2013/924206. Epub 2013 Feb 4. Review.

20.

Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs.

Amicone L, Citarella F, Cicchini C.

Biomed Res Int. 2015;2015:473942. doi: 10.1155/2015/473942. Epub 2015 Mar 10. Review.

Supplemental Content

Support Center